IP Library Granted Patent US 7,329,695
Granted Patent B2
US 7,329,695 · App. 10/654,114 · Granted Feb 12, 2008

Ink formulations and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,329,695
App. No.
10/654,114
Granted
Feb 12, 2008
Kind
B2
Abstract

The present invention provides a chemical ink for pad printing a medical device comprising water; a colorant; and a crosslinkable, water-soluble poly(vinyl alcohol). The ink has a viscosity of greater than 50 centipoise, and good adhesion to the medical device. Method for printing contact lenses with such ink are also disclosed.

Claims (35)

1. An ink for pad printing a medical device comprising: from about 1% and 59% by weight of water; from about 0.5% to about 8% by weight of a colorant; and from about 1% to about 75% by weight of a binder polymer, wherein the binder polymer is a crosslinkable, water-soluble poly(vinyl alcohol) having olefinically unsaturated radicals, provided that the ink does not include a crosslinker to crosslink two or more monomers or polymer molecules, wherein the ink has a viscosity of greater than 100 centipoise, wherein the ink without crosslinker has good adhesion to a medical device, wherein the water-soluble poly(vinyl alcohol) is a crosslinkable polymer based on a polyhydroxyl compound which is a derivative of a poly(vinyl alcohol) having a molecular weight of at least about 2000 which comprises from about 0.5 to about 80%, based on the number of hydroxyl groups in the poly(vinyl alcohol), of units of the formula I, I and II, I and III, or I and II and III

in which R is alkylene having up to 12 carbon atoms, R 1 is hydrogen or lower alkyl, R 2 is an olefinically unsaturated, electron-withdrawing, crosslinkable radical, preferably having up to 25 carbon atoms, and R 3 is hydrogen, a C 1 -C 6 alkyl group or a cycloalkyl group,

wherein R and R 3 are as defined for formula I above, and R 7 is a primary, secondary or tertiary amino group or a quaternary amino group of the formula N + (R′) 3 X − , in which each R′, independently of the others, is hydrogen or a C 1 -C 4 alkyl radical and X is a counter ion,

in which R and R 3 are as defined for formula I above, and R 8 is the radical of a monobasic, dibasic or tribasic, saturated or unsaturated, aliphatic or aromatic organic acid or sulfonic acid.

2. An ink of claim 1 , wherein a color image printed on a medical device with said ink, passes an autoclave-surviving test.

3. An ink of claim 1 , wherein the viscosity is from 100 to about 1000 cps.

4. An ink of claim 3 , wherein the viscosity is between 250 and 350 cps.

5. An ink of claim 1 , wherein the colorant is selected from the group consisting of a pigment and a dye which is either sparingly soluble or insoluble in water.

6. An ink of claim 5 , comprising water in an amount of from about 26% and 30% by weight.

7. An ink of claim 5 , comprising water-soluble poly (vinyl alcohol) in an amount of from about 47% o about 71% by weight.

8. An ink of claim 5 , comprising colorant in an amount of from about 1% to 5% by weight.

9. An ink of claim 5 , wherein said colorant comprises a pigment selected from the group consisting of phthalocyanine blue, cobalt blue, phthalocyanine green, chromium sesquioxide; iron oxide pigments, and carbazole violet.

10. An ink of claim 9 , wherein said colorant comprises phthalocyanine blue.

11. An ink of claim 10 , comprising water in an amount of from about 27% and 29% by weight by weight; crosslinkable water-soluble poly (vinyl alcohol) in an amount of from about 70% to about 72% by weight; and phthalocyanine blue in an amount from about 0.5 to about 1.5% by weight.

12. An ink of claim 10 , comprising water in an amount of from about 36% to 37% by weight by weight; crosslinkable water-soluble poly (vinyl alcohol) in an amount of from about 58% to about 60% by weight; and phthalocyanine blue in an amount from about 4% to about 5% by weight.

13. An ink of claim 1 , wherein the medical device is an ophthalmic lens.

14. An ink of claim 13 , wherein the ophthalmic lens is a contact lens.

15. An ink of claim 1 , wherein said poly (vinyl alcohol) comprises multiple crosslinkable groups; and the multiple crosslinkable groups are capable of forming inter- and intra crosslinkages with other crosslinkable groups of the same type or different type so that a macromolecular matrix can be formed to bind or trap pigments when cured.

16. An ink of claim 1 , wherein R 2 is a radical of the formula V

—[CO—NH—(R 5 —NH—CO—O) q —R 6 —O] p —CO—R 4   (V)

in which p and q, independently of one another, are zero or one, and R 5 and R 6 , independently of one another, are lower alkylene having 2 to 8 carbon atoms, arylene having 6 to 12 carbon atoms, a saturated bivalent cycloaliphatic group having 6 to 10 carbon atoms, arylenealkylene or alkylenearylene having 7 to 14 carbon atoms or arylenealkylenearylene having 13 to 16 carbon atoms, and in which R 4 is an olefinically unsaturated copolymerizable radical having 2 to 24 carbon atoms.

17. An ink of claim 16 , wherein R 4 is an olefinically unsaturated copolymerizable radical having 2 to 8 carbon atoms.

18. An ink of claim 1 , wherein the ink has a good transferability from a mold for making the contact lens to the contact lens.

19. An ink of claim 1 , wherein the ink is stable for at least 4 hours.

20. An ink of claim 19 , wherein the ink is stable for at least 24 hours.

21. An ink of claim 20 , wherein the ink is stable for at least three weeks.

22. An ink of claim 21 , wherein said crosslinkable poly(vinyl alcohol) is crosslinked by exposure to UV radiation.

23. A method for making a colored contact lens comprising the steps of:

(a) coating at least a portion of at least one lens-forming surface of a lens mold with a water-based ink comprising water; a colorant; and a binder polymer which is a crosslinkable, water-soluble poly(vinyl alcohol) having olefinically unsaturated radicals, provided that the ink does not include a cross linker to crosslink two or more monomers or polymer molecules, wherein the ink has a viscosity of greater than 100 centipoise, wherein the ink without crosslinker has good adhesion to a medical device, wherein the water-soluble poly(vinyl alcohol) is a crosslinkable polymer based on a polyhydroxyl compound which is a derivative of a poly(vinyl alcohol) having a molecular weight of at least about 2000 which comprises from about 0.5 to about 80%, based on the number of hydroxyl groups in the poly(vinyl alcohol), of units of the formula I, I and II, I and III, or I and II and III

in which R is alkylene having up to 12 carbon atoms, R 1 is hydrogen or lower alkyl, R 2 is an olefinically unsaturated, electron-withdrawing, crosslinkable radical, preferably having up to 25 carbon atoms, and R 3 is hydrogen, a C 1 -C 6 alkyl group or a cycloalkyl group,

wherein R and R 3 are as defined for formula I above, and R 7 is a primary, secondary or tertiary amino group or a quaternary amino group of the formula N + (R′) 3 X − , in which each R′, independently of the others, is hydrogen or a C 1 -C 4 alkyl radical and X is a counter ion,

in which R and R 3 are as defined for formula I above, and R 8 is the radical of a monobasic, dibasic or tribasic, saturated or unsaturated, aliphatic or aromatic organic acid or sulfonic acid;

(b) adding a lens forming composition to the lens mold while maintaining the color coat in position; and

(c) curing the lens-forming composition to form a coated lens;

wherein said contact lens is characterized by having no visible observation of colorant bleeding, smearing, or delamination after digitally rubbing said contact lens between either two fingers or a finger and a palm for approximately 10 seconds.

Assignments (2)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 28, 2007
From: TUCKER, ROBERT CAREY; CORTI, SANDRA
To: NOVARTIS AG
Reel/Frame 020177/0440 →